APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bioconjugates Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Bioconjugates Service Industry Growth and Trends Forecast to 2032

22 January 2026121 pages

Choose your research edition.

Industry ResearchBioconjugates Service Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Bioconjugates Service Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Bioconjugates Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bioconjugates Service Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Bioconjugates Service Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

According to APO Research, the global Bioconjugates Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bioconjugates Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bioconjugates Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bioconjugates Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Bioconjugates Service market include CellMosaic, AAT Bioquest, Creative Biolabs, Lonza, Bio-Synthesis, NJ Bio, Macrocyclics, KareBay and MuseChem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bioconjugates Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bioconjugates Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bioconjugates Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bioconjugates Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Bioconjugates Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bioconjugates Service Market by Company

CellMosaic

AAT Bioquest

Creative Biolabs

Lonza

Bio-Synthesis

NJ Bio

Macrocyclics

KareBay

MuseChem

CheMatech

Recipharm

Nanocs

Vector Laboratories

Cell Signaling Technology

Thermo Fisher

WuXi Biologics

Celares

GTP Bioways

Antibody Solutions

BOC Sciences

Novasep

Bioconjugates Service Segment by Type

Covalent Conjugation Service

Non-Covalent Conjugation Service

Site-specific Conjugation Service

Bioconjugates Service Segment by Application

Therapeutic Drug Development

Diagnostic Probe Manufacturing

Basic Biological Research

Other

Bioconjugates Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioconjugates Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bioconjugates Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioconjugates Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Bioconjugates Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Bioconjugates Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Bioconjugates Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Bioconjugates Service Market Share by Region (2021-2026) Table 4. Global Bioconjugates Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Bioconjugates Service Market Share by Region (2027-2032) Table 6. Global Bioconjugates Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Bioconjugates Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Bioconjugates Service Market Size Share by Type (2021-2026) Table 9. Global Bioconjugates Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Bioconjugates Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Bioconjugates Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Bioconjugates Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Bioconjugates Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Bioconjugates Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Bioconjugates Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Bioconjugates Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Bioconjugates Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Bioconjugates Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Bioconjugates Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Bioconjugates Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Bioconjugates Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Bioconjugates Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Bioconjugates Service Market Size Share by Application (2021-2026) Table 24. Global Bioconjugates Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Bioconjugates Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Bioconjugates Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Bioconjugates Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Bioconjugates Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Bioconjugates Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Bioconjugates Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Bioconjugates Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Bioconjugates Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Bioconjugates Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Bioconjugates Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Bioconjugates Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Bioconjugates Service Industry Trends Table 37. Bioconjugates Service Industry Drivers Table 38. Bioconjugates Service Industry Opportunities and Challenges Table 39. Bioconjugates Service Industry Restraints Table 40. Global Bioconjugates Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Bioconjugates Service Revenue Market Share by Company (2021-2026) Table 42. Global Bioconjugates Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Bioconjugates Service Key Company Headquarters & Area Served Table 44. Global Bioconjugates Service Company, Product Type & Application Table 45. Global Bioconjugates Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Bioconjugates Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. CellMosaic Company Information Table 49. CellMosaic Business Overview Table 50. CellMosaic Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. CellMosaic Bioconjugates Service Product Portfolio Table 52. CellMosaic Recent Development Table 53. AAT Bioquest Company Information Table 54. AAT Bioquest Business Overview Table 55. AAT Bioquest Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. AAT Bioquest Bioconjugates Service Product Portfolio Table 57. AAT Bioquest Recent Development Table 58. Creative Biolabs Company Information Table 59. Creative Biolabs Business Overview Table 60. Creative Biolabs Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Creative Biolabs Bioconjugates Service Product Portfolio Table 62. Creative Biolabs Recent Development Table 63. Lonza Company Information Table 64. Lonza Business Overview Table 65. Lonza Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Lonza Bioconjugates Service Product Portfolio Table 67. Lonza Recent Development Table 68. Bio-Synthesis Company Information Table 69. Bio-Synthesis Business Overview Table 70. Bio-Synthesis Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Bio-Synthesis Bioconjugates Service Product Portfolio Table 72. Bio-Synthesis Recent Development Table 73. NJ Bio Company Information Table 74. NJ Bio Business Overview Table 75. NJ Bio Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. NJ Bio Bioconjugates Service Product Portfolio Table 77. NJ Bio Recent Development Table 78. Macrocyclics Company Information Table 79. Macrocyclics Business Overview Table 80. Macrocyclics Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Macrocyclics Bioconjugates Service Product Portfolio Table 82. Macrocyclics Recent Development Table 83. KareBay Company Information Table 84. KareBay Business Overview Table 85. KareBay Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. KareBay Bioconjugates Service Product Portfolio Table 87. KareBay Recent Development Table 88. MuseChem Company Information Table 89. MuseChem Business Overview Table 90. MuseChem Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. MuseChem Bioconjugates Service Product Portfolio Table 92. MuseChem Recent Development Table 93. CheMatech Company Information Table 94. CheMatech Business Overview Table 95. CheMatech Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. CheMatech Bioconjugates Service Product Portfolio Table 97. CheMatech Recent Development Table 98. Recipharm Company Information Table 99. Recipharm Business Overview Table 100. Recipharm Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Recipharm Bioconjugates Service Product Portfolio Table 102. Recipharm Recent Development Table 103. Nanocs Company Information Table 104. Nanocs Business Overview Table 105. Nanocs Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Nanocs Bioconjugates Service Product Portfolio Table 107. Nanocs Recent Development Table 108. Vector Laboratories Company Information Table 109. Vector Laboratories Business Overview Table 110. Vector Laboratories Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Vector Laboratories Bioconjugates Service Product Portfolio Table 112. Vector Laboratories Recent Development Table 113. Cell Signaling Technology Company Information Table 114. Cell Signaling Technology Business Overview Table 115. Cell Signaling Technology Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Cell Signaling Technology Bioconjugates Service Product Portfolio Table 117. Cell Signaling Technology Recent Development Table 118. Thermo Fisher Company Information Table 119. Thermo Fisher Business Overview Table 120. Thermo Fisher Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Thermo Fisher Bioconjugates Service Product Portfolio Table 122. Thermo Fisher Recent Development Table 123. WuXi Biologics Company Information Table 124. WuXi Biologics Business Overview Table 125. WuXi Biologics Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. WuXi Biologics Bioconjugates Service Product Portfolio Table 127. WuXi Biologics Recent Development Table 128. Celares Company Information Table 129. Celares Business Overview Table 130. Celares Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Celares Bioconjugates Service Product Portfolio Table 132. Celares Recent Development Table 133. GTP Bioways Company Information Table 134. GTP Bioways Business Overview Table 135. GTP Bioways Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. GTP Bioways Bioconjugates Service Product Portfolio Table 137. GTP Bioways Recent Development Table 138. Antibody Solutions Company Information Table 139. Antibody Solutions Business Overview Table 140. Antibody Solutions Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Antibody Solutions Bioconjugates Service Product Portfolio Table 142. Antibody Solutions Recent Development Table 143. BOC Sciences Company Information Table 144. BOC Sciences Business Overview Table 145. BOC Sciences Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. BOC Sciences Bioconjugates Service Product Portfolio Table 147. BOC Sciences Recent Development Table 148. Novasep Company Information Table 149. Novasep Business Overview Table 150. Novasep Bioconjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Novasep Bioconjugates Service Product Portfolio Table 152. Novasep Recent Development Table 153. North America Bioconjugates Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Bioconjugates Service Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Bioconjugates Service Market Share by Country (2021-2026) Table 156. North America Bioconjugates Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Bioconjugates Service Market Share Forecast by Country (2027-2032) Table 158. Europe Bioconjugates Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Bioconjugates Service Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Bioconjugates Service Market Share by Country (2021-2026) Table 161. Europe Bioconjugates Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Bioconjugates Service Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Bioconjugates Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Bioconjugates Service Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Bioconjugates Service Market Share by Country (2021-2026) Table 166. Asia-Pacific Bioconjugates Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Bioconjugates Service Market Share Forecast by Country (2027-2032) Table 168. Latin America Bioconjugates Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Bioconjugates Service Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Bioconjugates Service Market Share by Country (2021-2026) Table 171. Latin America Bioconjugates Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Bioconjugates Service Market Share Forecast by Country (2027-2032) Table 173. Middle East & Africa Bioconjugates Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East & Africa Bioconjugates Service Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East & Africa Bioconjugates Service Market Share by Country (2021-2026) Table 176. Middle East & Africa Bioconjugates Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East & Africa Bioconjugates Service Market Share Forecast by Country (2027-2032) Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Bioconjugates Service Product Image Figure 3. Global Bioconjugates Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Bioconjugates Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Bioconjugates Service Market Share by Region: 2025 VS 2032 Figure 6. Global Bioconjugates Service Market Share by Region (2021-2032) Figure 7. North America Bioconjugates Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Bioconjugates Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Bioconjugates Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Bioconjugates Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Bioconjugates Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Covalent Conjugation Service Image Figure 13. Global Covalent Conjugation Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Non-Covalent Conjugation Service Image Figure 15. Global Non-Covalent Conjugation Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Site-specific Conjugation Service Image Figure 17. Global Site-specific Conjugation Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Bioconjugates Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Bioconjugates Service Market Share by Type 2025 VS 2032 Figure 20. North America Bioconjugates Service Market Size Share by Type (2021-2032) Figure 21. Europe Bioconjugates Service Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Bioconjugates Service Market Size Share by Type (2021-2032) Figure 23. Latin America Bioconjugates Service Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Bioconjugates Service Market Size Share by Type (2021-2032) Figure 25. Therapeutic Drug Development Image Figure 26. Global Therapeutic Drug Development Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Diagnostic Probe Manufacturing Image Figure 28. Global Diagnostic Probe Manufacturing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Basic Biological Research Image Figure 30. Global Basic Biological Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Other Image Figure 32. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Bioconjugates Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Bioconjugates Service Market Share by Application 2025 VS 2032 Figure 35. North America Bioconjugates Service Market Size Share by Application (2021-2032) Figure 36. Europe Bioconjugates Service Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Bioconjugates Service Market Size Share by Application (2021-2032) Figure 38. Latin America Bioconjugates Service Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Bioconjugates Service Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Bioconjugates Service Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Bioconjugates Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Bioconjugates Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Bioconjugates Service Market Share by Country (2021-2032) Figure 45. Europe Bioconjugates Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Bioconjugates Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Bioconjugates Service Market Share by Country (2021-2032) Figure 48. Asia-Pacific Bioconjugates Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Bioconjugates Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Bioconjugates Service Market Share by Country (2021-2032) Figure 51. Latin America Bioconjugates Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Bioconjugates Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Bioconjugates Service Market Share by Country (2021-2032) Figure 54. Middle East & Africa Bioconjugates Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Bioconjugates Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Bioconjugates Service Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Covalent Conjugation Service
  • Non-Covalent Conjugation Service
  • Site-specific Conjugation Service
Applications
  • Therapeutic Drug Development
  • Diagnostic Probe Manufacturing
  • Basic Biological Research
  • Other
Companies covered
  • CellMosaic
  • AAT Bioquest
  • Creative Biolabs
  • Lonza
  • Bio-Synthesis
  • NJ Bio
  • Macrocyclics
  • KareBay
  • MuseChem
  • CheMatech
  • Recipharm
  • Nanocs
  • Vector Laboratories
  • Cell Signaling Technology
  • Thermo Fisher
  • WuXi Biologics
  • Celares
  • GTP Bioways
  • Antibody Solutions
  • BOC Sciences
  • Novasep

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Bioconjugates Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Bioconjugates Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Bioconjugates Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Bioconjugates Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Bioconjugates Service Market Size (2021-2032)
  8. 1.5.1 North America Bioconjugates Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Bioconjugates Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Bioconjugates Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Bioconjugates Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Bioconjugates Service Market Size Growth Rate (2021-2032)
2 Bioconjugates Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Covalent Conjugation Service
  3. 2.1.2 Non-Covalent Conjugation Service
  4. 2.1.3 Site-specific Conjugation Service
  5. 2.2 Global Bioconjugates Service Market Size by Type
  6. 2.2.1 Global Bioconjugates Service Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Bioconjugates Service Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Bioconjugates Service Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Bioconjugates Service Market Size by Regions
  10. 2.3.1 North America Bioconjugates Service Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Bioconjugates Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Bioconjugates Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Bioconjugates Service Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Bioconjugates Service Market Size Breakdown by Type (2021-2026)
3 Bioconjugates Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Therapeutic Drug Development
  3. 3.1.2 Diagnostic Probe Manufacturing
  4. 3.1.3 Basic Biological Research
  5. 3.1.4 Other
  6. 3.2 Global Bioconjugates Service Market Size by Application
  7. 3.2.1 Global Bioconjugates Service Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Bioconjugates Service Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Bioconjugates Service Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Bioconjugates Service Market Size by Regions
  11. 3.3.1 North America Bioconjugates Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Bioconjugates Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Bioconjugates Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Bioconjugates Service Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Bioconjugates Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Bioconjugates Service Industry Trends
  2. 4.2 Bioconjugates Service Industry Drivers
  3. 4.3 Bioconjugates Service Industry Opportunities and Challenges
  4. 4.4 Bioconjugates Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Bioconjugates Service Revenue (2021-2026)
  2. 5.2 Global Bioconjugates Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Bioconjugates Service Key Company Headquarters & Area Served
  4. 5.4 Global Bioconjugates Service Company, Product Type & Application
  5. 5.5 Global Bioconjugates Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Bioconjugates Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Bioconjugates Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Bioconjugates Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 CellMosaic
  2. 6.1.1 CellMosaic Company Information
  3. 6.1.2 CellMosaic Business Overview
  4. 6.1.3 CellMosaic Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 CellMosaic Bioconjugates Service Product Portfolio
  6. 6.1.5 CellMosaic Recent Developments
  7. 6.2 AAT Bioquest
  8. 6.2.1 AAT Bioquest Company Information
  9. 6.2.2 AAT Bioquest Business Overview
  10. 6.2.3 AAT Bioquest Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 AAT Bioquest Bioconjugates Service Product Portfolio
  12. 6.2.5 AAT Bioquest Recent Developments
  13. 6.3 Creative Biolabs
  14. 6.3.1 Creative Biolabs Company Information
  15. 6.3.2 Creative Biolabs Business Overview
  16. 6.3.3 Creative Biolabs Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Creative Biolabs Bioconjugates Service Product Portfolio
  18. 6.3.5 Creative Biolabs Recent Developments
  19. 6.4 Lonza
  20. 6.4.1 Lonza Company Information
  21. 6.4.2 Lonza Business Overview
  22. 6.4.3 Lonza Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Lonza Bioconjugates Service Product Portfolio
  24. 6.4.5 Lonza Recent Developments
  25. 6.5 Bio-Synthesis
  26. 6.5.1 Bio-Synthesis Company Information
  27. 6.5.2 Bio-Synthesis Business Overview
  28. 6.5.3 Bio-Synthesis Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Bio-Synthesis Bioconjugates Service Product Portfolio
  30. 6.5.5 Bio-Synthesis Recent Developments
  31. 6.6 NJ Bio
  32. 6.6.1 NJ Bio Company Information
  33. 6.6.2 NJ Bio Business Overview
  34. 6.6.3 NJ Bio Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 NJ Bio Bioconjugates Service Product Portfolio
  36. 6.6.5 NJ Bio Recent Developments
  37. 6.7 Macrocyclics
  38. 6.7.1 Macrocyclics Company Information
  39. 6.7.2 Macrocyclics Business Overview
  40. 6.7.3 Macrocyclics Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Macrocyclics Bioconjugates Service Product Portfolio
  42. 6.7.5 Macrocyclics Recent Developments
  43. 6.8 KareBay
  44. 6.8.1 KareBay Company Information
  45. 6.8.2 KareBay Business Overview
  46. 6.8.3 KareBay Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 KareBay Bioconjugates Service Product Portfolio
  48. 6.8.5 KareBay Recent Developments
  49. 6.9 MuseChem
  50. 6.9.1 MuseChem Company Information
  51. 6.9.2 MuseChem Business Overview
  52. 6.9.3 MuseChem Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 MuseChem Bioconjugates Service Product Portfolio
  54. 6.9.5 MuseChem Recent Developments
  55. 6.10 CheMatech
  56. 6.10.1 CheMatech Company Information
  57. 6.10.2 CheMatech Business Overview
  58. 6.10.3 CheMatech Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 CheMatech Bioconjugates Service Product Portfolio
  60. 6.10.5 CheMatech Recent Developments
  61. 6.11 Recipharm
  62. 6.11.1 Recipharm Company Information
  63. 6.11.2 Recipharm Business Overview
  64. 6.11.3 Recipharm Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Recipharm Bioconjugates Service Product Portfolio
  66. 6.11.5 Recipharm Recent Developments
  67. 6.12 Nanocs
  68. 6.12.1 Nanocs Company Information
  69. 6.12.2 Nanocs Business Overview
  70. 6.12.3 Nanocs Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Nanocs Bioconjugates Service Product Portfolio
  72. 6.12.5 Nanocs Recent Developments
  73. 6.13 Vector Laboratories
  74. 6.13.1 Vector Laboratories Company Information
  75. 6.13.2 Vector Laboratories Business Overview
  76. 6.13.3 Vector Laboratories Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Vector Laboratories Bioconjugates Service Product Portfolio
  78. 6.13.5 Vector Laboratories Recent Developments
  79. 6.14 Cell Signaling Technology
  80. 6.14.1 Cell Signaling Technology Company Information
  81. 6.14.2 Cell Signaling Technology Business Overview
  82. 6.14.3 Cell Signaling Technology Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Cell Signaling Technology Bioconjugates Service Product Portfolio
  84. 6.14.5 Cell Signaling Technology Recent Developments
  85. 6.15 Thermo Fisher
  86. 6.15.1 Thermo Fisher Company Information
  87. 6.15.2 Thermo Fisher Business Overview
  88. 6.15.3 Thermo Fisher Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Thermo Fisher Bioconjugates Service Product Portfolio
  90. 6.15.5 Thermo Fisher Recent Developments
  91. 6.16 WuXi Biologics
  92. 6.16.1 WuXi Biologics Company Information
  93. 6.16.2 WuXi Biologics Business Overview
  94. 6.16.3 WuXi Biologics Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 WuXi Biologics Bioconjugates Service Product Portfolio
  96. 6.16.5 WuXi Biologics Recent Developments
  97. 6.17 Celares
  98. 6.17.1 Celares Company Information
  99. 6.17.2 Celares Business Overview
  100. 6.17.3 Celares Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Celares Bioconjugates Service Product Portfolio
  102. 6.17.5 Celares Recent Developments
  103. 6.18 GTP Bioways
  104. 6.18.1 GTP Bioways Company Information
  105. 6.18.2 GTP Bioways Business Overview
  106. 6.18.3 GTP Bioways Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 GTP Bioways Bioconjugates Service Product Portfolio
  108. 6.18.5 GTP Bioways Recent Developments
  109. 6.19 Antibody Solutions
  110. 6.19.1 Antibody Solutions Company Information
  111. 6.19.2 Antibody Solutions Business Overview
  112. 6.19.3 Antibody Solutions Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Antibody Solutions Bioconjugates Service Product Portfolio
  114. 6.19.5 Antibody Solutions Recent Developments
  115. 6.20 BOC Sciences
  116. 6.20.1 BOC Sciences Company Information
  117. 6.20.2 BOC Sciences Business Overview
  118. 6.20.3 BOC Sciences Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 BOC Sciences Bioconjugates Service Product Portfolio
  120. 6.20.5 BOC Sciences Recent Developments
  121. 6.21 Novasep
  122. 6.21.1 Novasep Company Information
  123. 6.21.2 Novasep Business Overview
  124. 6.21.3 Novasep Bioconjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Novasep Bioconjugates Service Product Portfolio
  126. 6.21.5 Novasep Recent Developments
7 North America
  1. 7.1 North America Bioconjugates Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Bioconjugates Service Market Size by Country (2021-2026)
  3. 7.3 North America Bioconjugates Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Bioconjugates Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Bioconjugates Service Market Size by Country (2021-2026)
  3. 8.3 Europe Bioconjugates Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Bioconjugates Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Bioconjugates Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Bioconjugates Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Bioconjugates Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Bioconjugates Service Market Size by Country (2021-2026)
  3. 10.3 South America Bioconjugates Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Bioconjugates Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Bioconjugates Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Bioconjugates Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst